RE:RE:RE:RE:RE:RE:Projected share price is $4.11 Letsmake1 wrote: Thanks Raps!
It appears to be the Covid test that has driven the sp recently?
This seems to be a very competitive field
What is the VST edge in this space?
Do you place much value on the rest of the portfolio or is it the Covid test that most are betting on?
Where did the $4.11 sp come from?
Do you see much more of a pullback off the high or do you think there will be more news soon to propel it up?
Thanks again....I know theseare questions for IR but it's Sunday and patience is not my strength ;)
Cheers
The company is a venture accelerator. They have a nice mix of portfolio companies (23 currently) focusing on disruptive tech leading the way in the 4th industrial revolution. VS Health (portfolio company) which VST owns 20% equity stake in, has recently received FDA permission to sell and manufacture their rapid Covid19 Antibody test as well as ANVISA approval in Brazil and EU approval for sale and use in the European Union. General consensus is that contract and sales news will be the next domino to fall. One to keep your on. The company owns 100% distribution rights for sales to certain regions outside of Brazil. Come for the covid and stay for the vast other catalysts. The $4.11 SP came from there LD 500 conference recently to investors, where they stated there forcast is at 300 million 4.11 SP. We are nearing a point where I assume the bombshell of contract news is around the corner, hopefully this week. Shorts are going to continue to drop SP and try to take all profits from retails. I see this week no news we will be testing the 60's and 50's. With news I truly believe this stock headed over 1$ and by Christmas time a SP of 2-7$. Best regards and goodluck